F. Amenta et F. Ferrante, ENDOTHELIN-1 DISPLACES [H-3] NICARDIPINE BINDING IN SECTIONS OF HUMANRENAL-ARTERY, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000171-190000173
Endothelin-1 (ET-1) is a potent vasoconstrictor peptide, the actions o
f which are mediated through interaction with specific ET receptors. F
unctional evidence has shown that the constrictor effect of ET may req
uire extracellular Ca2+. Ca2+ antagonists of the dihydropyridine famil
y attenuate the vasoconstriction caused by ET. However, the basis of t
he interactions between ET and dihydropyridine agents are not well und
erstood. Our study was designed to assess whether different concentrat
ions of ET-1 or ET-3 have any effect on [H-3]nicardipine binding to se
ctions of human renal artery. [H-3]Nicardipine was specifically bound
to sections of the human renal artery. Binding sites, which were locat
ed primarily over smooth muscle of the tunica media, showed the pharma
cologic profile typical of a dihydropyridine Ca2+ channel. Increasing
concentrations of ET-1, but not of ET-3, competed dose-dependently wit
h [H-3]nicardipine binding. A 1-nM concentration of ET-1 lessened spec
ific [H-3]nicardipine binding by approximately 80%. These results sugg
est the occurrence of an interaction in the human renal artery between
dihydropyridine Ca2+ channels and ET-1. This interaction probably acc
ounts for the inhibition of the ET-1-mediated vasoconstriction elicite
d by nicardipine.